arrow
J

Jorge Wong

mcmaster university
H指数:24
被引数:3,872

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rationale, design, and experiences from the vanguard phase of the bariatric surgery for the reduction of cardiovascular events (BRAVE) trial

BRAVE试验先锋阶段减肥手术减少心血管事件的原理、设计与经验

2026-08-010
PRE
Early recurrence of atrial arrhythmia and healthcare utilization during the 8-week blanking period following thermal energy catheter ablation of atrial fibrillation

心房心律失常的早期复发及在心房颤动热能导管消融术后8周空白期内的医疗资源利用

2025-12-080
OAAI
Monitoring time-to-detection of recurrent atrial fibrillation in patients with transient new-onset atrial fibrillation detected initially during hospitalization for noncardiac surgery or medical illness

监测因非心脏手术或内科疾病住院期间初次发现的一过性新发房颤患者中复发性房颤的检测时间

2025-10-100
OAAI
Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

设备检测到的亚临床心房颤动患者中心房颤动进展:ARTESiA试验的见解

2025-07-090
PRE
ZW220, a NaPi2b-directed topoisomerase I inhibitor Antibody-Drug Conjugate, demonstrates compelling preclinical activity in NSCLC, ovarian and uterine cancer models, with a favorable toxicology profile in non-human primates
2024-10-010
PRE
A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome

钙释放缺乏综合征的临床诊断试验

2024-07-162
PRE
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

阿哌沙班用于预防亚临床心房颤动的卒中

2024-01-11141
OA
Rhythm vs. Rate Control in Patients with Postoperative Atrial Fibrillation after Cardiac Surgery: A Systematic Review and Meta-Analysis

心律控制与心率控制在心脏手术后房颤患者中的应用: 系统评价和Meta分析

2023-07-075
OAAI
Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale
2022-12-012
PRE